Martingale Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,534
| Closed | -$202K | – | 861 |
|
|
2024
Q1 | $202K | Sell |
1,534
-7,363
| -83% | -$920K | ﹤0.01% | 778 |
|
|
2023
Q4 | $1.08M | Sell |
8,897
-11,440
| -56% | -$1.28M | 0.02% | 435 |
|
|
2023
Q3 | $2.28M | Sell |
20,337
-186
| -0.9% | -$23.6K | 0.05% | 238 |
|
|
2023
Q2 | $2.99M | Buy |
+20,523
| New | +$2.79M | 0.06% | 201 |
|
|
2021
Q4 | – | Sell |
-1,415
| Closed | -$202K | – | 902 |
|
|
2021
Q3 | $202K | Sell |
1,415
-91
| -6% | -$13.4K | ﹤0.01% | 823 |
|
|
2021
Q2 | $236K | Sell |
1,506
-8
| -0.5% | -$1.3K | ﹤0.01% | 773 |
|
|
2021
Q1 | $236K | Sell |
1,514
-19,417
| -93% | -$3.01M | ﹤0.01% | 792 |
|
|
2020
Q4 | $3.13M | Sell |
20,931
-17,628
| -46% | -$2.49M | 0.04% | 253 |
|
|
2020
Q3 | $5.1M | Sell |
38,559
-275,619
| -88% | -$36M | 0.06% | 216 |
|
|
2020
Q2 | $36.4M | Sell |
314,178
-4,388
| -1% | -$506K | 0.43% | 67 |
|
|
2020
Q1 | $31.3M | Buy |
318,566
+77,257
| +32% | +$10.1M | 0.42% | 71 |
|
|
2019
Q4 | $35.1M | Sell |
241,309
-12,875
| -5% | -$1.78M | 0.36% | 91 |
|
|
2019
Q3 | $33.9M | Sell |
254,184
-20,587
| -7% | -$2.66M | 0.35% | 96 |
|
|
2019
Q2 | $31.4M | Buy |
274,771
+11,948
| +5% | +$1.4M | 0.33% | 104 |
|
|
2019
Q1 | $32.6M | Buy |
262,823
+19,471
| +8% | +$2.21M | 0.35% | 92 |
|
|
2018
Q4 | $24.5M | Buy |
243,352
+39,008
| +19% | +$4.39M | 0.32% | 104 |
|
|
2018
Q3 | $26.1M | Sell |
204,344
-724
| -0.4% | -$86.1K | 0.31% | 113 |
|
|
2018
Q2 | $22.2M | Sell |
205,068
-30,426
| -13% | -$3.31M | 0.27% | 122 |
|
|
2018
Q1 | $24.9M | Buy |
235,494
+52,666
| +29% | +$6.12M | 0.32% | 106 |
|
|
2017
Q4 | $21.4M | Buy |
182,828
+41,840
| +30% | +$4.73M | 0.28% | 124 |
|
|
2017
Q3 | $16M | Sell |
140,988
-12,480
| -8% | -$1.44M | 0.22% | 144 |
|
|
2017
Q2 | $19.1M | Sell |
153,468
-13,819
| -8% | -$1.64M | 0.27% | 128 |
|
|
2017
Q1 | $19.8M | Sell |
167,287
-43,712
| -21% | -$4.95M | 0.29% | 121 |
|
|
2016
Q4 | $21.1M | Sell |
210,999
-59,866
| -22% | -$6.42M | 0.3% | 114 |
|
|
2016
Q3 | $34.2M | Buy |
270,865
+264,732
| +4,317% | +$32.7M | 0.51% | 43 |
|
|
2016
Q2 | $717K | Buy |
6,133
+1,678
| +38% | +$190K | 0.01% | 599 |
|
|
2016
Q1 | $462K | Sell |
4,455
-1
| -0% | -$97 | 0.01% | 666 |
|
|
2015
Q4 | $444K | Sell |
4,456
-1,721
| -28% | -$168K | 0.01% | 675 |
|
|
2015
Q3 | $564K | Hold |
6,177
| – | – | 0.01% | 626 |
|
|
2015
Q2 | $656K | Sell |
6,177
-64,430
| -91% | -$7.13M | 0.02% | 633 |
|
|
2015
Q1 | $8.06M | Buy |
70,607
+14,216
| +25% | +$1.62M | 0.19% | 170 |
|
|
2014
Q4 | $6.21M | Buy |
56,391
+30,953
| +122% | +$3.26M | 0.17% | 180 |
|
|
2014
Q3 | $2.48M | Hold |
25,438
| – | – | 0.08% | 267 |
|
|
2014
Q2 | $2.57M | Sell |
25,438
-66,779
| -72% | -$6.52M | 0.08% | 268 |
|
|
2014
Q1 | $8.47M | Buy |
92,217
+33,681
| +58% | +$3.1M | 0.29% | 104 |
|
|
2013
Q4 | $5.3M | Sell |
58,536
-34,729
| -37% | -$3.01M | 0.18% | 161 |
|
|
2013
Q3 | $7.44M | Sell |
93,265
-280
| -0.3% | -$22K | 0.27% | 106 |
|
|
2013
Q2 | $6.81M | Buy |
+93,545
| New | +$6.99M | 0.25% | 114 |
|
Other funds holding ZBH
Martingale Asset Management's ZBH Position: Q2 2024 in Review
Martingale Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 1,534 shares — an estimated $202K sold.
Martingale Asset Management first reported a position in ZBH in Q2 2013 and held it in 38 quarters. The position peaked at $36.4M in Q2 2020. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.
- Martingale Asset Management reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
- Martingale Asset Management sold 1,534 Zimmer Biomet shares in Q2 2024, an estimated $202K.
- Martingale Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 38 quarters.
- Martingale Asset Management's Zimmer Biomet position peaked at $36.4M in Q2 2020.
- 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.
Based on Martingale Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.